Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis.
AUTOR(ES)
Booji, A
RESUMO
OBJECTIVE: To examine the possible beneficial effect of androgens in postmenopausal women with active rheumatoid arthritis. METHODS: 107 women participated in a double blind placebo controlled trial to evaluate the effect of 50 mg testosterone propionate intramuscularly every two weeks for one year. RESULTS: An improvement in ESR, Dutch health assessment questionnaire, and pain was noted. In addition, 21% of patients treated with testosterone fulfilled the ACR improvement criteria after one year, versus only 4% of the placebo group. The treatment was well tolerated. CONCLUSIONS: Testosterone may improve the general wellbeing of postmenopausal women with active rheumatoid arthritis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1010316Documentos Relacionados
- Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.
- Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.
- Infectious arthritis in patients with rheumatoid arthritis.
- Role of androgens in the aetiology of rheumatoid arthritis.
- An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis.
